← FDA Drug Approvals (Drugs@FDA)
RAPIBLYK
NDA · New Drug Application · Sponsor: AOP HLTH US · Approved 2024-11-22
Drug application
- FDA Application #
NDA217202- Application type
- New Drug Application
- Brand name
- RAPIBLYK
- Generic name
- LANDIOLOL
- Active ingredients
- LANDIOLOL HYDROCHLORIDE
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- AOP HLTH US
- Manufacturer
- AOP Orphan Pharmaceuticals GmbH
- First approval
- 2024-11-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown